Published in J Am Coll Cardiol on January 21, 2004
Retracted C-reactive protein in aortic valve disease. Cardiovasc Ultrasound (2006) 1.12
C-reactive protein in degenerative aortic valve stenosis. Cardiovasc Ultrasound (2006) 1.11
Why is aortic sclerosis associated with adverse clinical outcomes? J Am Coll Cardiol (2004) 1.07
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patients. Heart Vessels (2013) 0.91
Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. Diabetes Care (2012) 0.90
Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart (2005) 0.89
Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha. Am J Pathol (2010) 0.87
Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol (2014) 0.83
Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study). Am J Cardiol (2007) 0.82
Insights into aortic sclerosis and its relationship with coronary artery disease. J Am Heart Assoc (2014) 0.80
The effects of long-term regular exercise on endothelial functions, inflammatory and thrombotic activity in middle-aged, healthy men. J Sports Sci Med (2006) 0.77
Impact of Valve Morphology on the Prevalence of Coronary Artery Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.75
Study of Aortic Valve Sclerosis as A Marker of Atherosclerosis in Acute Coronary Syndromes. J Clin Diagn Res (2016) 0.75
Biomarkers of Calcific Aortic Valve Disease. Arterioscler Thromb Vasc Biol (2017) 0.75
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol (2005) 6.07
A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol (2007) 3.83
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol (2006) 3.82
A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol (2002) 3.52
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol (2008) 2.46
Fibrinolytic therapy: is it a treatment of the past? Circulation (2003) 2.27
Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Imaging (2012) 2.19
Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol (2004) 2.14
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina? Catheter Cardiovasc Interv (2003) 2.06
Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol (2004) 2.03
Simplified scoring system for predicting mortality after percutaneous coronary intervention. J Am Coll Cardiol (2003) 1.84
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol (2004) 1.83
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation (2004) 1.83
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv (2009) 1.76
The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function. J Thorac Cardiovasc Surg (2008) 1.70
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
Resolution of refractory no-reflow with intracoronary epinephrine. Catheter Cardiovasc Interv (2002) 1.64
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Am J Cardiol (2006) 1.62
Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol (2005) 1.62
Features of disrupted plaques by coronary computed tomographic angiography: correlates with invasively proven complex lesions. Circ Cardiovasc Imaging (2011) 1.60
Composition of target lesions by near-infrared spectroscopy in patients with acute coronary syndrome versus stable angina. Circ Cardiovasc Interv (2012) 1.59
Range and prevalence of cardiac abnormalities in patients hospitalized in a medical ICU. Chest (2002) 1.56
The truth and consequences of the COURAGE trial. J Am Coll Cardiol (2007) 1.55
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol (2005) 1.52
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol (2002) 1.51
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study. Catheter Cardiovasc Interv (2013) 1.50
Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. J Am Coll Cardiol (2003) 1.49
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation (2004) 1.48
Coronary angiography by computed tomography: coronary imaging evolves. J Am Coll Cardiol (2007) 1.47
Usefulness of embolic protection devices during saphenous vein graft intervention in a nonselected population. J Interv Cardiol (2005) 1.42
A novel complete radiation protection system eliminates physician radiation exposure and leaded aprons. Catheter Cardiovasc Interv (2012) 1.41
Rescue angioplasty: does the concept need to be rescued? J Am Coll Cardiol (2004) 1.40
The diagnostic accuracy of 64-slice computed tomography coronary angiography compared with stress nuclear imaging in emergency department low-risk chest pain patients. Ann Emerg Med (2006) 1.40
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J (2005) 1.39
Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR. Catheter Cardiovasc Interv (2013) 1.38
A tale of two pressures: a case of pseudo-prosthetic mitral valve stenosis. Catheter Cardiovasc Interv (2011) 1.38
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study. J Invasive Cardiol (2016) 1.38
Impact of CMS coverage decision on access to transcatheter aortic valve replacement. Catheter Cardiovasc Interv (2014) 1.38
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. JACC Cardiovasc Imaging (2009) 1.37
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA (2003) 1.36
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J (2010) 1.36
Acute cardiac effects of marathon running. J Appl Physiol (1985) (2010) 1.32
Diagnosis, management, and clinical outcome of cardiac tamponade complicating percutaneous coronary intervention. Am J Cardiol (2002) 1.31
Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol (2004) 1.27
Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol (2013) 1.24
Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2013) 1.21
Rapid medical relief--Project Medishare and the Haitian earthquake. N Engl J Med (2010) 1.17
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol (2007) 1.14
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol (2004) 1.13
Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation (2004) 1.13
Risk of bleeding after elective percutaneous coronary intervention. N Engl J Med (2006) 1.12
One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty. Am J Cardiol (2003) 1.11
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial). Am J Cardiol (2004) 1.09
Occupational health hazards in the interventional laboratory: time for a safer environment. Radiology (2009) 1.09
Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol (2007) 1.07
Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol (2003) 1.07
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol (2011) 1.05
One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg (2005) 1.04
The long-term consequences of lost intracoronary stents. J Interv Cardiol (2002) 0.99
Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2005) 0.98
Retrograde percutaneous aortic valve implantation for critical aortic stenosis. Catheter Cardiovasc Interv (2005) 0.96
Success, safety, and mechanisms of failure of percutaneous coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery total occlusion. Am J Cardiol (2005) 0.92
A Bayesian meta-analysis comparing AngioJet thrombectomy to percutaneous coronary intervention alone in acute myocardial infarction. J Interv Cardiol (2008) 0.91
Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol (2004) 0.91
Occupational health hazards in the interventional laboratory: time for a safer environment. Catheter Cardiovasc Interv (2009) 0.91
Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). Am J Cardiol (2003) 0.90
A case against low-volume percutaneous coronary intervention centers. Circulation (2009) 0.90
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv (2006) 0.89
Safety of percutaneous transfemoral coronary and peripheral procedures via aortofemoral synthetic vascular grafts. Am J Cardiol (2005) 0.89
Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol (2002) 0.87
Patterns of coronary compromise resulting in acute right ventricular ischemic dysfunction. Circulation (2002) 0.87
Analysis of target lesion length before coronary artery stenting using angiography and near-infrared spectroscopy versus angiography alone. Am J Cardiol (2011) 0.87
Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational study. Transplantation (2010) 0.86
Frequency of returning to work one and six months following percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2004) 0.86
Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - a contemporary experience. Catheter Cardiovasc Interv (2013) 0.86
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J (2009) 0.85
Acute angiographic analysis of non-ST-segment elevation acute myocardial infarction. Am J Cardiol (2004) 0.85
Rationale and study design of the CardioGene Study: genomics of in-stent restenosis. Pharmacogenomics (2004) 0.85
The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. J Am Coll Cardiol (2013) 0.85
Occlusion of a saphenous vein graft aneurysm with a vein-covered stent. J Interv Cardiol (2002) 0.84
Right versus left ventricular shock: a tale of two ventricles. J Am Coll Cardiol (2003) 0.84
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. Eur Heart J (2008) 0.83
Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction. Am J Cardiol (2003) 0.83
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study). Am J Cardiol (2008) 0.83
Cardiac biomarkers - the old and the new: a review. Coron Artery Dis (2010) 0.83